BIOMAT Database Logo BIOMAT Database Logo

Circulating heparin-like substance following liver injury. 1970

J M Little, and I Bailey, and H Kronenberg, and J P Halliday

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012769 Shock A pathological condition manifested by failure to perfuse or oxygenate vital organs. Circulatory Collapse,Circulatory Failure,Hypovolemic Shock,Collapse, Circulatory,Failure, Circulatory,Shock, Hypovolemic

Related Publications

J M Little, and I Bailey, and H Kronenberg, and J P Halliday
Circulating heparin-like substance after liver injury.
June 1970, Lancet (London, England),
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
Circulating heparin-like anticoagulant following portacaval anastomosis.
September 1970, Lancet (London, England),
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
Circulating heparin-like anticoagulants.
October 1984, The New England journal of medicine,
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
Circulating reticuloendothelial depressing substance following thermal injury and intestinal ischemia.
April 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
Circulating heparin during liver transplantation.
April 1993, Transplantation proceedings,
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
Endothelial injury from a circulating mediator following rat liver ischemia.
February 1998, Free radical biology & medicine,
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
The thrombolytic effect of heparin and a heparin-like substance, SP 54.
May 1967, Thrombosis et diathesis haemorrhagica,
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
[Determination of heparin-like substance in blood-improved method].
November 1965, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
[Circulating heparin-like anticoagulant--2 cases of successful therapy].
May 1992, Vnitrni lekarstvi,
J M Little, and I Bailey, and H Kronenberg, and J P Halliday
Report of three cases of circulating heparin-like anticoagulants.
August 2001, American journal of hematology,
Copied contents to your clipboard!